Skip to main content
NiceBooksReadsSTORIES BRING US TOGETHER
DiscoverWhat’s Being Read?UK booksellers
BooksEbooksAudiobooks
World Literature NewsBook FriendshipBook roomsBook Club
Creation StudiosPublish Your Own BookExperts
EnglishUS

Market controls currency, catalogue and payment options; it does not change your language.

Log inJoin
NiceBooksReadsSTORIES BRING US TOGETHER
Language
EnglishUS

Market controls currency, catalogue and payment options; it does not change your language.

Discover
⌕Discover›↗What’s Being Read?›↗UK booksellers›
Read & Listen
▥Books›▤Ebooks›▶Audiobooks›
Community
✦World Literature News›♡Book Friendship›◌Book rooms›▧Book Club›
Write & Publish
✦Creation Studios›↗Publish Your Own Book›◇Experts›
Log inJoin
← Back to library

Source and use notice

You are accessing this work through its Internet Archive source record. NiceBooksReads provides access to the source and a reading/listening interface.

Rights in the work and recording belong to their respective rights holders. Please review the source record’s licence, access and use conditions. This notice grants no additional use or republication rights.

Source record ↗Source terms of use ↗
Anatabine Supplementation Decreases Thyroglobulin Antibodies in Patients With Chronic Lymphocytic Autoimmune (Hashimoto's) Thyroiditis: A Randomized Controlled Clinical Trial.

English

Anatabine Supplementation Decreases Thyroglobulin Antibodies in Patients With Chronic Lymphocytic Autoimmune (Hashimoto's) Thyroiditis: A Randomized Controlled Clinical Trial.

Lowell R. SchmeltzThomas C. BlevinsStephen L. AronoffKerem OzerJonathan D. LeffertMarc A. GoldbergBarry S. HorowitzRichard H. Bertenshaw

This article is from The Journal of Clinical Endocrinology and Metabolism , volume 99 . Abstract Context:: Hashimoto's thyroiditis is less prevalent in tobacco smokers. Anatabine, an alkaloid found in Solanaceae plants including tobacco, has been reported to ameliorate a mouse model of Hashimoto's thyroiditis. Objective:: The effects of anatabine in patients with Hashimoto's thyroiditis were studied. Design, Setting, Patients, and Intervention:: This was a double-blind, randomized, placebo-controlled multisite study. A total of 146 patients (70 treated with anatabine and 76 with placebo) completed the study. Approximately 50% of patients in each group were taking levothyroxine. Anatabine lozenges (9–24 mg/d) or placebo, each containing vitamins A and D3, were administered orally 3 times a day for 3 months. Main Outcome Measures:: Serum thyroperoxidase antibody (TPOAb) and thyroglobulin antibody (TgAb) levels were assessed. Safety was assessed through adverse events, clinical laboratory evaluations, and vital sign measurements. Results:: Anatabine-treated patients had a significant reduction in absolute serum TgAb levels from baseline by study end relative to those receiving placebo

Sign in with your free account to read, download EPUBs or listen.

Read online →EPUB ↓

Report a problem with this book

Anatabine Supplementation Decreases Thyroglobulin Antibodies in Patients With Chronic Lymphocytic Autoimmune (Hashimoto's) Thyroiditis: A Randomized Controlled Clinical Trial.

About this work

Ebook · Anatabine Supplementation Decreases Thyroglobulin Antibodies in Patients With Chronic Lymphocytic Autoimmune (Hashimoto's) Thyroiditis: A Randomized Controlled Clinical Trial. · Schmeltz, Lowell R., Blevins, Thomas C., Aronoff, Stephen L., Ozer, Kerem, Leffert, Jonathan D., Goldberg, Marc A., Horowitz, Barry S., Bertenshaw, Richard H. · Internet Archive

Digital editions

EPUB ↓

Find other editions →

NiceBooksReadsSTORIES BRING US TOGETHER

A creative community where stories are written, read, heard and shaped with professional publishing services.

DiscoverBooksWhat’s Being Read?World Literature News
Privacy & cookiesUser agreementDistance sales agreementCookie settings
●Secure connectionProtected with HTTPS and SSL/TLS encryption
Payment cards
VISAmastercardtroy
© 2026 NiceBooksReads · All rights reserved.